Literature DB >> 22837074

Image cytometry-based detection of aneuploidy by fluorescence in situ hybridization in suspension.

Hans Minderman1, Kristen Humphrey, Jane K Arcadi, Andrzej Wierzbicki, Orla Maguire, Eunice S Wang, AnneMarie W Block, Sheila N J Sait, Thaddeus C George, Paul K Wallace.   

Abstract

Cytogenetic abnormalities are important diagnostic and prognostic criteria for hematologic malignancies. Karyotyping and fluorescence in situ hybridization (FISH) are the conventional methods by which these abnormalities are detected. The sensitivity of these microscopy-based methods is limited by the abundance of the abnormal cells in the samples and therefore these analyses are commonly not applicable to minimal residual disease (MRD) stages. A flow cytometry-based imaging approach was developed to detect chromosomal abnormalities following FISH in suspension (FISH-IS), which enables the automated analysis of several log-magnitude higher number of cells compared with the microscopy-based approaches. This study demonstrates the applicability of FISH-IS for detecting numerical chromosome aberrations, establishes accuracy, and sensitivity of detection compared with conventional FISH, and feasibility to study procured clinical samples of acute myeloid leukemia (AML). Male and female healthy donor peripheral blood mononuclear cells hybridized with combinations of chromosome enumeration probes (CEP) 8, X, and Y served as models for disomy, monosomy, and trisomy. The sensitivity of detection of monosomies and trisomies amongst 20,000 analyzed cells was determined to be 1% with a high level of precision. A high correlation (R(2) = 0.99) with conventional FISH analysis was found based on the parallel analysis of diagnostic samples procured from 10 AML patients with trisomy 8 (+8). Additionally, FISH-IS analysis of samples procured at the time of clinical remission demonstrated the presence of residual +8 cells indicating that this approach may be used to detect MRD and associated chromosomal defects.
Copyright © 2012 International Society for Advancement of Cytometry.

Entities:  

Mesh:

Year:  2012        PMID: 22837074      PMCID: PMC4384178          DOI: 10.1002/cyto.a.22101

Source DB:  PubMed          Journal:  Cytometry A        ISSN: 1552-4922            Impact factor:   4.355


  28 in total

1.  Simultaneous flow cytometric analysis of cell surface markers and telomere length: analysis of human tonsilar B cells.

Authors:  F M Batliwalla; R N Damle; C Metz; N Chiorazzi; P K Gregersen
Journal:  J Immunol Methods       Date:  2001-01-01       Impact factor: 2.303

Review 2.  Beyond morphology: minimal residual disease detection in acute myeloid leukemia.

Authors:  Courtney D DiNardo; Selina M Luger
Journal:  Curr Opin Hematol       Date:  2012-03       Impact factor: 3.284

Review 3.  Fluorescence in situ Hybridization (FISH).

Authors:  Jane Bayani; Jeremy A Squire
Journal:  Curr Protoc Cell Biol       Date:  2004-09

4.  A clinically relevant population of leukemic CD34(+)CD38(-) cells in acute myeloid leukemia.

Authors:  Jonathan M Gerber; B Douglas Smith; Brownhilda Ngwang; Hao Zhang; Milada S Vala; Laura Morsberger; Steven Galkin; Michael I Collector; Brandy Perkins; Mark J Levis; Constance A Griffin; Saul J Sharkis; Michael J Borowitz; Judith E Karp; Richard J Jones
Journal:  Blood       Date:  2012-01-19       Impact factor: 22.113

5.  High-risk cytogenetics and persistent minimal residual disease by multiparameter flow cytometry predict unsustained complete response after autologous stem cell transplantation in multiple myeloma.

Authors:  Bruno Paiva; Norma C Gutiérrez; Laura Rosiñol; María-Belén Vídriales; María-Ángeles Montalbán; Joaquín Martínez-López; María-Victoria Mateos; María-Teresa Cibeira; Lourdes Cordón; Albert Oriol; María-José Terol; María-Asunción Echeveste; Raquel de Paz; Felipe de Arriba; Luis Palomera; Javier de la Rubia; Joaquín Díaz-Mediavilla; Anna Sureda; Ana Gorosquieta; Adrian Alegre; Alejandro Martin; Miguel T Hernández; Juan-José Lahuerta; Joan Bladé; Jesús F San Miguel
Journal:  Blood       Date:  2011-11-29       Impact factor: 22.113

6.  Feasibility of simultaneous fluorescence immunophenotyping and fluorescence in situ hybridization study for the detection of estrogen receptor expression and deletions of the estrogen receptor gene in breast carcinoma cell lines.

Authors:  Y Zhang; R Siebert; P Matthiesen; S Harder; M Theile; S Scherneck; B Schlegelberger
Journal:  Virchows Arch       Date:  2000-03       Impact factor: 4.064

7.  Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study.

Authors:  M L Slovak; K J Kopecky; P A Cassileth; D H Harrington; K S Theil; A Mohamed; E Paietta; C L Willman; D R Head; J M Rowe; S J Forman; F R Appelbaum
Journal:  Blood       Date:  2000-12-15       Impact factor: 22.113

Review 8.  Review of the relevance of aberrant antigen expression by flow cytometry in myeloid neoplasms.

Authors:  Gert J Ossenkoppele; Arjan A van de Loosdrecht; Gerrit Jan Schuurhuis
Journal:  Br J Haematol       Date:  2011-03-09       Impact factor: 6.998

9.  Fluorescence immunophenotypic and interphase cytogenetic characterization of nodal lymphoplasmacytic lymphoma.

Authors:  Rachel Lynn Sargent; James R Cook; Nadine I Aguilera; Urvashi Surti; Susan L Abbondanzo; Susanne M Gollin; Steven H Swerdlow
Journal:  Am J Surg Pathol       Date:  2008-11       Impact factor: 6.394

Review 10.  The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.

Authors:  James W Vardiman; Jüergen Thiele; Daniel A Arber; Richard D Brunning; Michael J Borowitz; Anna Porwit; Nancy Lee Harris; Michelle M Le Beau; Eva Hellström-Lindberg; Ayalew Tefferi; Clara D Bloomfield
Journal:  Blood       Date:  2009-04-08       Impact factor: 22.113

View more
  7 in total

1.  Cytometry in the brain: studying differentiation to diagnostic applications in brain disease and regeneration therapy.

Authors:  H Ulrich; J Bocsi; T Glaser; A Tárnok
Journal:  Cell Prolif       Date:  2014-02       Impact factor: 6.831

2.  Simultaneous Analysis of Phenotype and Cytogenetics Using Imaging Flow Cytometry: Time to Teach Old Dogs New Tricks.

Authors:  Hans Minderman
Journal:  Cytometry A       Date:  2019-04-22       Impact factor: 4.355

3.  Enhanced γ-H2AX DNA damage foci detection using multimagnification and extended depth of field in imaging flow cytometry.

Authors:  Christopher N Parris; Sheba Adam Zahir; Hussein Al-Ali; Emma C Bourton; Christina Plowman; Piers N Plowman
Journal:  Cytometry A       Date:  2015-06-18       Impact factor: 4.355

4.  In aged primary T cells, mitochondrial stress contributes to telomere attrition measured by a novel imaging flow cytometry assay.

Authors:  Sharon Lesley Sanderson; Anna Katharina Simon
Journal:  Aging Cell       Date:  2017-08-19       Impact factor: 9.304

5.  Fluorescent In Situ Hybridization in Suspension by Imaging Flow Cytometry.

Authors:  Orla Maguire; Paul K Wallace; Hans Minderman
Journal:  Methods Mol Biol       Date:  2016

6.  FISH+CD34+CD38- cells detected in newly diagnosed acute myeloid leukemia patients can predict the clinical outcome.

Authors:  Libing Wang; Lei Gao; Sheng Xu; Shenglan Gong; Li Chen; Shuqing Lü; Jie Chen; Huiying Qiu; Xiaoqian Xu; Xiong Ni; Xianmin Song; Weiping Zhang; Jianmin Yang; Min Liu; Xiaoxia Hu; Jianmin Wang
Journal:  J Hematol Oncol       Date:  2013-11-07       Impact factor: 17.388

7.  Non-random Mis-segregation of Human Chromosomes.

Authors:  Joseph Thomas Worrall; Naoka Tamura; Alice Mazzagatti; Nadeem Shaikh; Tineke van Lingen; Bjorn Bakker; Diana Carolina Johanna Spierings; Elina Vladimirou; Floris Foijer; Sarah Elizabeth McClelland
Journal:  Cell Rep       Date:  2018-06-12       Impact factor: 9.423

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.